| IHTPA-1mg Human tissue plasminogen activator, 85% single chain 1mg Innovative Research INC 1mg 1619 |
IHTPA-1mg |
Human tissue plasminogen activator, 85% single chain 1mg
|
Innovative Research INC |
1mg |
1619 |
|
Publication |
| IHTPA-0.1mg Human tissue plasminogen activator, 85% single chain 0.1mg Innovative Research INC 0.1mg 504 |
IHTPA-0.1mg |
Human tissue plasminogen activator, 85% single chain 0.1mg
|
Innovative Research INC |
0.1mg |
504 |
|
Publication |
| MD-14-1161 Rabbit Anti-Mouse Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 328 |
MD-14-1161 |
Rabbit Anti-Mouse Tissue Plasminogen Activator (tPA) PLAT Antibodies
|
Ray Biotech |
200 |
328 |
|
Publication |
| E03T0010 Mouse anti-Tissue type Plasminogen Activator ELISA Kit BlueGen 96 Tests/kit 1087.8 |
E03T0010 |
Mouse anti-Tissue type Plasminogen Activator ELISA Kit
|
BlueGen |
96 Tests/kit |
1087.8 |
|
Publication |
| MD-14-0576 Rabbit Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 411 |
MD-14-0576 |
Rabbit Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies
|
Ray Biotech |
200 |
411 |
|
Publication |
| MD-14-0575 Mouse Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 411 |
MD-14-0575 |
Mouse Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies
|
Ray Biotech |
200 |
411 |
|
Publication |
| mAP-0143 Rat monoclonal anti mouse Urokinase-type Plasminogen Activator Receptor (uPAR) Anti-Mouse antibodies AngoiPro 100.00 ug 310 |
mAP-0143 |
Rat monoclonal anti mouse Urokinase-type Plasminogen Activator Receptor (uPAR) Anti-Mouse antibodies
|
AngoiPro |
100.00 ug |
310 |
|
Publication |
| IQ435 Mouse Antihuman neutrophil CAP18 Target Antigen neutrophil CAP18 Host Isotype Mouse IgG1 Application IF; WB; Imunquest 0.1ml (1mg/ml) 492 |
IQ435 |
Mouse Antihuman neutrophil CAP18 Target Antigen neutrophil CAP18 Host Isotype Mouse IgG1 Application IF; WB;
|
Imunquest |
0.1ml (1mg/ml) |
492 |
|
Publication |
| LF-MA0190 anti-Plasminogen (44A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 |
LF-MA0190 |
anti-Plasminogen (44A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse
|
Abfrontier |
100 ul |
355 |
|
Publication |
| LF-MA0189 anti-Plasminogen (9A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 |
LF-MA0189 |
anti-Plasminogen (9A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse
|
Abfrontier |
100 ul |
355 |
|
Publication |
| LF-MA0170 anti-Plasminogen, Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 |
LF-MA0170 |
anti-Plasminogen, Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse
|
Abfrontier |
100 ul |
355 |
|
Publication |
| orb60025 Thymosin alpha 1 Thymosin alpha 1(Zadaxin), also known as thymalfasin has immunoregulatory properties enhancing immune functions. For research use only. Biorb 100 mg 583 |
orb60025 |
Thymosin alpha 1 Thymosin alpha 1(Zadaxin), also known as thymalfasin has immunoregulatory properties enhancing immune functions. For research use only.
|
Biorb |
100 mg |
583 |
|
Publication |
| 305-14551 Anti PDX1 Polyclonal Antibody, Rabbit Pancreas duodenum homeobox 1 (PDX1) is a transcription factor encoded by homeodomein gene. This protein promotes the transcription of the pancreatic genes such as B-Bridge 25UG 854.7 |
305-14551 |
Anti PDX1 Polyclonal Antibody, Rabbit Pancreas duodenum homeobox 1 (PDX1) is a transcription factor encoded by homeodomein gene. This protein promotes the transcription of the pancreatic genes such as
|
B-Bridge |
25UG |
854.7 |
|
Publication |
| IHNE-0.5mg Human Neutrophil Elastase 0.5mg Innovative Research INC 0.5mg 264 |
IHNE-0.5mg |
Human Neutrophil Elastase 0.5mg
|
Innovative Research INC |
0.5mg |
264 |
|
Publication |
| 4716-100 Elastase, Human Neutrophil Biovision 100 µg 400 |
4716-100 |
Elastase, Human Neutrophil
|
Biovision |
100 µg |
400 |
|
Publication |
| 4713-100 Cathepsin G, Human Neutrophil Biovision 100 µg 411 |
4713-100 |
Cathepsin G, Human Neutrophil
|
Biovision |
100 µg |
411 |
|
Publication |
| 4744-100 Myeloperoxidase, Human Neutrophil Biovision 100 µg 240 |
4744-100 |
Myeloperoxidase, Human Neutrophil
|
Biovision |
100 µg |
240 |
|
Publication |
| 201-12-0342 Human neutrophil peptide 1-3,HNP1-3 ELISA Kit SunBT 96T 476 |
201-12-0342 |
Human neutrophil peptide 1-3,HNP1-3 ELISA Kit
|
SunBT |
96T |
476 |
|
Publication |
| K782-100 Neutrophil Elastase Inhibitor Screening Kit Biovision 100 assays 425 |
K782-100 |
Neutrophil Elastase Inhibitor Screening Kit
|
Biovision |
100 assays |
425 |
|
Publication |
| bs-6982R Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody Sepax 100ug Lyophilized 222 |
bs-6982R |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody
|
Sepax |
100ug Lyophilized |
222 |
|
Publication |
| CSB-EL010048HU Human guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 |
CSB-EL010048HU |
Human guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasma
|
Cusabio |
96T |
913 |
|
Publication |
| bs-6982R-Cy5 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 |
bs-6982R-Cy5 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy5 conjugated, Isotype: IgG
|
Sepax |
100ug Lyophilized |
268 |
|
Publication |
| bs-6982R-PE-Cy5 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 |
bs-6982R-PE-Cy5 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG
|
Sepax |
100ug Lyophilized |
300 |
|
Publication |
| bs-6982R-Cy3 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 |
bs-6982R-Cy3 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy3 conjugated, Isotype: IgG
|
Sepax |
100ug Lyophilized |
268 |
|
Publication |
| bs-6982R-HRP Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 |
bs-6982R-HRP |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, HRP conjugated Isotype: IgG
|
Sepax |
100ug Lyophilized |
284 |
|
Publication |
| bs-6982R-Cy7 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 |
bs-6982R-Cy7 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy7 conjugated Isotype: IgG
|
Sepax |
100ug Lyophilized |
268 |
|
Publication |
| bs-6982R-PE-Cy7 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 |
bs-6982R-PE-Cy7 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG
|
Sepax |
100ug Lyophilized |
300 |
|
Publication |
| bs-6982R-Cy5.5 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 |
bs-6982R-Cy5.5 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG
|
Sepax |
100ug Lyophilized |
268 |
|
Publication |
| bs-6982R-PE-Cy5.5 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 |
bs-6982R-PE-Cy5.5 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG
|
Sepax |
100ug Lyophilized |
300 |
|
Publication |
| bs-6982R-Biotin Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Biotin conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 |
bs-6982R-Biotin |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Biotin conjugated, Isotype: IgG
|
Sepax |
100ug Lyophilized |
268 |
|
Publication |
| bs-6982R-FITC Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 |
bs-6982R-FITC |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, FITC conjugated,Isotype: IgG
|
Sepax |
100ug Lyophilized |
304 |
|
Publication |
| IRPLG-1mg Rat Plasminogen 1mg Innovative Research INC 1mg 816 |
IRPLG-1mg |
Rat Plasminogen 1mg
|
Innovative Research INC |
1mg |
816 |
|
Publication |
| bs-6982R-A488 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-6982R-A488 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG
|
Sepax |
100ug Lyophilized |
323 |
|
Publication |
| bs-6982R-A350 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-6982R-A350 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG
|
Sepax |
100ug Lyophilized |
323 |
|
Publication |
| bs-6982R-A647 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-6982R-A647 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG
|
Sepax |
100ug Lyophilized |
323 |
|
Publication |
| bs-6982R-A555 Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-6982R-A555 |
Rabbit Anti-Neutrophil Elastase ELANE Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG
|
Sepax |
100ug Lyophilized |
323 |
|
Publication |
| IHGPG-1mg Human Glu Plasminogen 1mg Innovative Research INC 1mg 421 |
IHGPG-1mg |
Human Glu Plasminogen 1mg
|
Innovative Research INC |
1mg |
421 |
|
Publication |
| IDPLG-1mg Canine Plasminogen 1mg Innovative Research INC 1mg 949 |
IDPLG-1mg |
Canine Plasminogen 1mg
|
Innovative Research INC |
1mg |
949 |
|
Publication |
| IBPLG-1mg Bovine Plasminogen 1mg Innovative Research INC 1mg 478 |
IBPLG-1mg |
Bovine Plasminogen 1mg
|
Innovative Research INC |
1mg |
478 |
|
Publication |
| ICKPG-1mg Chicken Plasminogen 1mg Innovative Research INC 1mg 535 |
ICKPG-1mg |
Chicken Plasminogen 1mg
|
Innovative Research INC |
1mg |
535 |
|
Publication |
| IRbPLG-1mg Rabbit Plasminogen 1mg Innovative Research INC 1mg 878 |
IRbPLG-1mg |
Rabbit Plasminogen 1mg
|
Innovative Research INC |
1mg |
878 |
|
Publication |
| IMPLG-1mg Mouse Plasminogen 1mg Innovative Research INC 1mg 374 |
IMPLG-1mg |
Mouse Plasminogen 1mg
|
Innovative Research INC |
1mg |
374 |
|
Publication |
| IHGPG-10mg Human Glu Plasminogen 10mg Innovative Research INC 1162 |
IHGPG-10mg |
Human Glu Plasminogen 10mg
|
Innovative Research INC |
|
1162 |
|
Publication |
| IRKTAH1167 Pig Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 597 |
IRKTAH1167 |
Pig Plasminogen ELISA Kit
|
Innovative Research INC |
1 kit(96 Wells) |
597 |
|
Publication |
| IDGPLGKT Dog Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 |
IDGPLGKT |
Dog Plasminogen ELISA Kit
|
Innovative Research INC |
1 kit(96 Wells) |
619 |
|
Publication |
| IBPLG-10mg Bovine Plasminogen 10mg Innovative Research INC 1805 |
IBPLG-10mg |
Bovine Plasminogen 10mg
|
Innovative Research INC |
|
1805 |
|
Publication |
| IRTPLGKT Rat Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 |
IRTPLGKT |
Rat Plasminogen ELISA Kit
|
Innovative Research INC |
1 kit(96 Wells) |
619 |
|
Publication |
| MD-14-0929 Rat Anti-Mouse Plasminogen PLG Antibodies Ray Biotech 100 386 |
MD-14-0929 |
Rat Anti-Mouse Plasminogen PLG Antibodies
|
Ray Biotech |
100 |
386 |
|
Publication |
| DS-MB-03405 Mouse Anti-Human Plasminogen Ray Biotech 200 566 |
DS-MB-03405 |
Mouse Anti-Human Plasminogen
|
Ray Biotech |
200 |
566 |
|
Publication |
| IHGPG Plasma Proteins: Human Glu Plasminogen Innovative Research INC 1mg 284 |
IHGPG |
Plasma Proteins: Human Glu Plasminogen
|
Innovative Research INC |
1mg |
284 |
|
Publication |
| IRBPLGKT Rabbit Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 |
IRBPLGKT |
Rabbit Plasminogen ELISA Kit
|
Innovative Research INC |
1 kit(96 Wells) |
619 |
|
Publication |
| MD-14-0071P Native Human Plasminogen Proteins Ray Biotech 1 mg 205 |
MD-14-0071P |
Native Human Plasminogen Proteins
|
Ray Biotech |
1 mg |
205 |
|
Publication |
| IASHNE-AS Antibodies, Rabbit: Anti-Elastase, Human Neutrophil, Rabbit Standard Antisera Innovative Research INC 1.0ml 518 |
IASHNE-AS |
Antibodies, Rabbit: Anti-Elastase, Human Neutrophil, Rabbit Standard Antisera
|
Innovative Research INC |
1.0ml |
518 |
|
Publication |
| IASHMPO-GF Antibodies, Rabbit: Anti-Myeloperoxidase, Human Neutrophil, Rabbit IgG Fraction Innovative Research INC 1.0ml 518 |
IASHMPO-GF |
Antibodies, Rabbit: Anti-Myeloperoxidase, Human Neutrophil, Rabbit IgG Fraction
|
Innovative Research INC |
1.0ml |
518 |
|
Publication |
| mAP-0089 Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-2) Anti-Mouse antibodies AngoiPro 100.00 ug 310 |
mAP-0089 |
Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-2) Anti-Mouse antibodies
|
AngoiPro |
100.00 ug |
310 |
|
Publication |
| mAP-0088 Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-1) Anti-Mouse antibodies AngoiPro 100.00 ug 310 |
mAP-0088 |
Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-1) Anti-Mouse antibodies
|
AngoiPro |
100.00 ug |
310 |
|
Publication |
| IASMPLG-1ml Rabbit Anti Mouse Plasminogen Antiserum 1ml Innovative Research INC 1ml 880 |
IASMPLG-1ml |
Rabbit Anti Mouse Plasminogen Antiserum 1ml
|
Innovative Research INC |
1ml |
880 |
|
Publication |
| IMPLA-SER-PG-50ml Plasminogen Depleted Mouse Serum 50ml Innovative Research INC 1220 |
IMPLA-SER-PG-50ml |
Plasminogen Depleted Mouse Serum 50ml
|
Innovative Research INC |
|
1220 |
|
Publication |
| DS-PB-01625 Sheep Anti-Human Plasminogen Antibodies Ray Biotech 1 ml 353 |
DS-PB-01625 |
Sheep Anti-Human Plasminogen Antibodies
|
Ray Biotech |
1 ml |
353 |
|
Publication |
| DS-PB-03022 Sheep Anti-Human Plasminogen [+HRP] Antibodies Ray Biotech 1 ml 411 |
DS-PB-03022 |
Sheep Anti-Human Plasminogen [+HRP] Antibodies
|
Ray Biotech |
1 ml |
411 |
|
Publication |
| IASMPLG-GF-1mg Rabbit Anti Mouse Plasminogen IgG Fraction 1mg Innovative Research INC 1mg 880 |
IASMPLG-GF-1mg |
Rabbit Anti Mouse Plasminogen IgG Fraction 1mg
|
Innovative Research INC |
1mg |
880 |
|
Publication |
| IFIB-25mg Human Fibrinogen, Plasminogen Depleted 25mg Innovative Research INC 126 |
IFIB-25mg |
Human Fibrinogen, Plasminogen Depleted 25mg
|
Innovative Research INC |
|
126 |
|
Publication |
| DS-PB-02729 Rabbit Anti-Human Plasminogen Antibodies Ray Biotech 1 ml 370 |
DS-PB-02729 |
Rabbit Anti-Human Plasminogen Antibodies
|
Ray Biotech |
1 ml |
370 |
|
Publication |
| T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| IPLG2F6C6 Antibodies, Mouse: Anti Human Plasminogen, Clone 2F6-C6 Innovative Research INC 1.0mg 752 |
IPLG2F6C6 |
Antibodies, Mouse: Anti Human Plasminogen, Clone 2F6-C6
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| DS-PB-01627 Sheep Anti-Human Plasminogen (Kringles 1-3) Antibodies Ray Biotech 0.2 ml 411 |
DS-PB-01627 |
Sheep Anti-Human Plasminogen (Kringles 1-3) Antibodies
|
Ray Biotech |
0.2 ml |
411 |
|
Publication |
| IASMPLG-GF-HRP-1mg Rabbit anti mouse plasminogen IgG fraction, HRP labeled 1mg Innovative Research INC 1mg 1002 |
IASMPLG-GF-HRP-1mg |
Rabbit anti mouse plasminogen IgG fraction, HRP labeled 1mg
|
Innovative Research INC |
1mg |
1002 |
|
Publication |
| IPLG9F9C4 Antibodies, Mouse: Anti Human Plasminogen, Clone 9F9-C4 Innovative Research INC 1.0mg 752 |
IPLG9F9C4 |
Antibodies, Mouse: Anti Human Plasminogen, Clone 9F9-C4
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| IMPLGKT-TOT Mouse Plasminogen Total Antigen Assay Innovative Research INC 1 kit(96 Wells) 453 |
IMPLGKT-TOT |
Mouse Plasminogen Total Antigen Assay
|
Innovative Research INC |
1 kit(96 Wells) |
453 |
|
Publication |
| DS-PB-03021 Sheep Anti-Human Plasminogen [+FITC] Antibodies Ray Biotech 1 ml 353 |
DS-PB-03021 |
Sheep Anti-Human Plasminogen [+FITC] Antibodies
|
Ray Biotech |
1 ml |
353 |
|
Publication |
| IPLG4G6B11 Antibodies, Mouse: Anti Human Plasminogen, Clone 4G6-B11 Innovative Research INC 1.0mg 752 |
IPLG4G6B11 |
Antibodies, Mouse: Anti Human Plasminogen, Clone 4G6-B11
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| IHPLGKT-TOT Human Plasminogen Total Antigen Assay Innovative Research INC 1 kit(96 Wells) 326 |
IHPLGKT-TOT |
Human Plasminogen Total Antigen Assay
|
Innovative Research INC |
1 kit(96 Wells) |
326 |
|
Publication |
| IPLG1C10F2 Antibodies, Mouse: Anti Human Plasminogen, Clone 1C10-F2 Innovative Research INC 1.0mg 752 |
IPLG1C10F2 |
Antibodies, Mouse: Anti Human Plasminogen, Clone 1C10-F2
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| IFIB Plasma Proteins: Human Fibrinogen, Plasminogen Depleted Innovative Research INC 1 Gram 302 |
IFIB |
Plasma Proteins: Human Fibrinogen, Plasminogen Depleted
|
Innovative Research INC |
1 Gram |
302 |
|
Publication |
| IPLG13C3B10 Antibodies, Mouse: Anti Human Plasminogen, Clone 13C3-B10 Innovative Research INC 1.0mg 752 |
IPLG13C3B10 |
Antibodies, Mouse: Anti Human Plasminogen, Clone 13C3-B10
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| IASMPLG-GF-BIO-1mg Rabbit Anti Mouse Plasminogen IgG Fraction, Biotin Labeled 1mg Innovative Research INC 1mg 1002 |
IASMPLG-GF-BIO-1mg |
Rabbit Anti Mouse Plasminogen IgG Fraction, Biotin Labeled 1mg
|
Innovative Research INC |
1mg |
1002 |
|
Publication |
| IPLG11B5B2 Plasma Proteins: Anti Human Plasminogen, Clone 11B5-B2 Innovative Research INC 1.0mg 752 |
IPLG11B5B2 |
Plasma Proteins: Anti Human Plasminogen, Clone 11B5-B2
|
Innovative Research INC |
1.0mg |
752 |
|
Publication |
| IASMPLG-FITC-1mg Rabbit Anti Mouse Plasminogen IgG Fraction, Fluorescein Labeled 1mg Innovative Research INC 1mg 1002 |
IASMPLG-FITC-1mg |
Rabbit Anti Mouse Plasminogen IgG Fraction, Fluorescein Labeled 1mg
|
Innovative Research INC |
1mg |
1002 |
|
Publication |
| IASMPLG-GF-HT-0.1mg Rabbit Anti Mouse Plasminogen Affinity Purified High Titer IgG Fraction 0.1mg Innovative Research INC 0.1mg 1002 |
IASMPLG-GF-HT-0.1mg |
Rabbit Anti Mouse Plasminogen Affinity Purified High Titer IgG Fraction 0.1mg
|
Innovative Research INC |
0.1mg |
1002 |
|
Publication |
| 188-01473 RANK Ligand Soluble, Human, recombinant (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related ac B-Bridge 1 mg 0 |
188-01473 |
RANK Ligand Soluble, Human, recombinant (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related ac
|
B-Bridge |
1 mg |
0 |
|
Publication |
| SO482 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
SO482 |
Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| SO8012 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores US Biomax 278 |
SO8012 |
Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores
|
US Biomax |
|
278 |
|
Publication |
| SO801 Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases 80 cores US Biomax 231 |
SO801 |
Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BC24011 Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231 |
BC24011 |
Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
| BR721 Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs US Biomax 231 |
BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231 |
|
Publication |
| T242 Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 |
T242 |
Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T203 Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 cores US Biomax 88 |
T203 |
Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115
|
US Biomax |
|
266 |
|
Publication |
| T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90 |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T243 |
Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006
|
US Biomax |
|
266 |
|
Publication |
| EIAAB27788 CAR,CAR,Constitutive activator of retinoid response,Constitutive active response,Constitutive androstane receptor,Homo sapiens,Human,NR1I3,Nuclear receptor subfamily 1 group I member 3,Orphan nuclear EIAab 1109 |
EIAAB27788 |
CAR,CAR,Constitutive activator of retinoid response,Constitutive active response,Constitutive androstane receptor,Homo sapiens,Human,NR1I3,Nuclear receptor subfamily 1 group I member 3,Orphan nuclear
|
EIAab |
|
1109 |
|
Publication |
| BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231 |
|
Publication |
| PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266 |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802
|
US Biomax |
|
266 |
|
Publication |
| BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456 |
|
Publication |
| SO809 Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores US Biomax 231 |
SO809 |
Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| ISASHPLG-GF-BIO Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, biotin labeled Innovative Research INC 1.0mg 460 |
ISASHPLG-GF-BIO |
Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, biotin labeled
|
Innovative Research INC |
1.0mg |
460 |
|
Publication |
| ISASHPLG-GF-HRP Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, HRP labeled Innovative Research INC 1.0mg 460 |
ISASHPLG-GF-HRP |
Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, HRP labeled
|
Innovative Research INC |
1.0mg |
460 |
|
Publication |
| ISASHPLG-GF-FITC Proteins and Antibodies Human and Animal Sheep anti human plasminogen IgG fraction, FITC labeled Innovative Research INC 1mg 421 |
ISASHPLG-GF-FITC |
Proteins and Antibodies Human and Animal Sheep anti human plasminogen IgG fraction, FITC labeled
|
Innovative Research INC |
1mg |
421 |
|
Publication |
| ISASHPLG-GF Antibodies, Sheep: Sheep anti human plasminogen IgG fraction Innovative Research INC 1.0mg 395 |
ISASHPLG-GF |
Antibodies, Sheep: Sheep anti human plasminogen IgG fraction
|
Innovative Research INC |
1.0mg |
395 |
|
Publication |
| SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456 |
SO2084 |
Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| IFIB-1Gram Human Fibrinogen, Plasminogen Depleted 1 Gram Innovative Research INC 1 Gram 404 |
IFIB-1Gram |
Human Fibrinogen, Plasminogen Depleted 1 Gram
|
Innovative Research INC |
1 Gram |
404 |
|
Publication |
| IMPLA-SER-PG-10ml Plasminogen Depleted Mouse Serum 10ml Innovative Research INC 10ml 633 |
IMPLA-SER-PG-10ml |
Plasminogen Depleted Mouse Serum 10ml
|
Innovative Research INC |
10ml |
633 |
|
Publication |
| ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores US Biomax 516 |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516 |
|
Publication |
| LC1002 Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013 US Biomax 231 |
LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231 |
|
Publication |
| BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 US Biomax 231 |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231 |
|
Publication |
| IRbPLG-10mg Rabbit Plasminogen 10mg Innovative Research INC 10mg 6970 |
IRbPLG-10mg |
Rabbit Plasminogen 10mg
|
Innovative Research INC |
10mg |
6970 |
|
Publication |
| ICKPG-10mg Chicken Plasminogen 10mg Innovative Research INC 10mg 4147 |
ICKPG-10mg |
Chicken Plasminogen 10mg
|
Innovative Research INC |
10mg |
4147 |
|
Publication |
| mAP-0307 Rat monoclonal anti mouse Plasminogen Kringle 5 Anti-Mouse antibodies AngoiPro 100.00 ug 310 |
mAP-0307 |
Rat monoclonal anti mouse Plasminogen Kringle 5 Anti-Mouse antibodies
|
AngoiPro |
100.00 ug |
310 |
|
Publication |
| BC00116 Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores US Biomax 231 |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
| RE802 Rectal normal adjacent tissue and cancer tissue array, 74 cases 80 cores US Biomax 231 |
RE802 |
Rectal normal adjacent tissue and cancer tissue array, 74 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| T323 Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88 |
T323 |
Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BN06012 Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores US Biomax 160 |
BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| LC481 Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores US Biomax 160 |
LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores US Biomax 456 |
LY2081 |
Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| BN06011 Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores US Biomax 160 |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
| CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores US Biomax 231 |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
| CO243 Colon cancer tissue array with normal tissue controls, 9 cases 24 cores US Biomax 88 |
CO243 |
Colon cancer tissue array with normal tissue controls, 9 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| RE481 Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases 48 cores US Biomax 160 |
RE481 |
Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166 |
SFD241 |
Human soft tissue disease tissue array, 24 cases 24 cores
|
US Biomax |
|
166 |
|
Publication |
| GL482 Brain tumor tissue array, with normal tissue, 48 cases 48 cores US Biomax 231 |
GL482 |
Brain tumor tissue array, with normal tissue, 48 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
| OS803 Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011 US Biomax 266 |
OS803 |
Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011
|
US Biomax |
|
266 |
|
Publication |
| FDA992 FDA normal organ tissue array of human tissue, 67cases 100 cores US Biomax 278 |
FDA992 |
FDA normal organ tissue array of human tissue, 67cases 100 cores
|
US Biomax |
|
278 |
|
Publication |
| LC1007 Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores US Biomax 231 |
LC1007 |
Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
| ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores US Biomax 231 |
ES8011 |
Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| LC803 Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array US Biomax 231 |
LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231 |
|
Publication |
| CO482 Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores US Biomax 160 |
CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| LV806 Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores US Biomax 231 |
LV806 |
Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BC15012 Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 231 |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
| BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores US Biomax 266 |
BR1006 |
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
| BC02013 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| LC1004 Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores US Biomax 231 |
LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
| MNO381 Tissue profiling tissue array with 19 types of normal human tissues, 19 cases 38 cores US Biomax 166 |
MNO381 |
Tissue profiling tissue array with 19 types of normal human tissues, 19 cases 38 cores
|
US Biomax |
|
166 |
|
Publication |
| RE801 Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231 |
RE801 |
Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 US Biomax 266 |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011
|
US Biomax |
|
266 |
|
Publication |
| BC07014 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| BC02012 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| ST991 Stomach adenocarcinoma (combination of margin and normal tissue) tissue array, 33 cases 99 cores US Biomax 231 |
ST991 |
Stomach adenocarcinoma (combination of margin and normal tissue) tissue array, 33 cases 99 cores
|
US Biomax |
|
231 |
|
Publication |
| BC09012 Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231 |
BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
| BC04012 Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores US Biomax 160 |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| BC19013 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores US Biomax 231 |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
| BC05012 Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores. US Biomax 231 |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231 |
|
Publication |
| ST802 Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores US Biomax 231 |
ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BC11012 Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores US Biomax 160 |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| LC801 Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores US Biomax 189 |
LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189 |
|
Publication |
| BC04021 Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| BC06011 Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores US Biomax 160 |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| KD801 Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231 |
KD801 |
Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| OV807 Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases 80 cores US Biomax 231 |
OV807 |
Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores US Biomax 189 |
GL242 |
Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores US Biomax 266 |
HN801 |
Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores US Biomax 91 |
FMC402 |
Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores
|
US Biomax |
|
91 |
|
Publication |
| ST801 Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231 |
ST801 |
Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| MC962 Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores US Biomax 0 |
MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores
|
US Biomax |
|
0 |
|
Publication |
| SK208 Skin cancer and normal tissue high density (69 cases 208 core) tissue microarray US Biomax 456 |
SK208 |
Skin cancer and normal tissue high density (69 cases 208 core) tissue microarray
|
US Biomax |
|
456 |
|
Publication |
| BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores US Biomax 314 |
BR8011 |
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores
|
US Biomax |
|
314 |
|
Publication |
| BC04015 Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 160 |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160 |
|
Publication |
| KD208 High density tissue array (70 cases 208 cores) of kidney cancer and normal tissue US Biomax 456 |
KD208 |
High density tissue array (70 cases 208 cores) of kidney cancer and normal tissue
|
US Biomax |
|
456 |
|
Publication |
| T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88 |
T263 |
Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266 |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012
|
US Biomax |
|
266 |
|
Publication |
| GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores US Biomax 266 |
GL808 |
Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| ST208 Stomach cancer and normal tissue high density (70 cases 208 core) tissue microarray US Biomax 456 |
ST208 |
Stomach cancer and normal tissue high density (70 cases 208 core) tissue microarray
|
US Biomax |
|
456 |
|
Publication |
| LV241 Liver cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88 |
LV241 |
Liver cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| LV801 Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases 80 cores US Biomax 231 |
LV801 |
Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| OV801 Ovarian cancer tissue array, with matched or unmatched adjacent normal tissue, 70 cases 80 cores US Biomax 231 |
OV801 |
Ovarian cancer tissue array, with matched or unmatched adjacent normal tissue, 70 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| SM241 Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases 24 cores US Biomax 88 |
SM241 |
Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD485 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores US Biomax 456 |
ES208 |
High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| LV20812 Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores US Biomax 456 |
LV20812 |
Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| LP801 Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 cores US Biomax 231 |
LP801 |
Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| UT241 Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM data US Biomax 100 |
UT241 |
Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM data
|
US Biomax |
|
100 |
|
Publication |
| KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
KD243 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456 |
|
Publication |
| CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores US Biomax 231 |
CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| T204 Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T204 |
Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| SK482 Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores US Biomax 160 |
SK482 |
Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| TMA2081 High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue US Biomax 456 |
TMA2081 |
High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue
|
US Biomax |
|
456 |
|
Publication |
| SO241 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores US Biomax 88 |
SO241 |
Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
LC485 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores US Biomax 266 |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| PA242 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
PA242 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| ES241 Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88 |
ES241 |
Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| LV804 Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011 US Biomax 231 |
LV804 |
Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011
|
US Biomax |
|
231 |
|
Publication |
| LV631 Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores US Biomax 231 |
LV631 |
Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores
|
US Biomax |
|
231 |
|
Publication |
| LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores US Biomax 231 |
GL801 |
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| CO241 Colon cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88 |
CO241 |
Colon cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| LC501 Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores US Biomax 160 |
LC501 |
Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160 |
|
Publication |
| BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013 US Biomax 231 |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231 |
|
Publication |
| UT242a Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 24 cores US Biomax 100 |
UT242a |
Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 24 cores
|
US Biomax |
|
100 |
|
Publication |
| BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data US Biomax 189 |
BO481 |
Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data
|
US Biomax |
|
189 |
|
Publication |
| BN07012 Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803 US Biomax 160 |
BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160 |
|
Publication |
| BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores US Biomax 231 |
BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| LC483 Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores US Biomax 160 |
LC483 |
Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483 US Biomax 397 |
BM482 |
Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483
|
US Biomax |
|
397 |
|
Publication |
| BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information US Biomax 266 |
BR1002 |
Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information
|
US Biomax |
|
266 |
|
Publication |
| OS801 Osteosarcoma and chondrosarcoma tissue array, with matched or unmatched adjacent normal tissue, 79 cases 80 cores US Biomax 266 |
OS801 |
Osteosarcoma and chondrosarcoma tissue array, with matched or unmatched adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| BN04011 Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725 US Biomax 160 |
BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160 |
|
Publication |
| TOP4-240 High density tissue array of top 4 types of cancers with normal tissue control, 220 cases 240 cores US Biomax 456 |
TOP4-240 |
High density tissue array of top 4 types of cancers with normal tissue control, 220 cases 240 cores
|
US Biomax |
|
456 |
|
Publication |
| SFT961 Soft tissue tumor tissue array, 48 cases 96 cores US Biomax 225 |
SFT961 |
Soft tissue tumor tissue array, 48 cases 96 cores
|
US Biomax |
|
225 |
|
Publication |
| BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores US Biomax 231 |
BCN721 |
Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores
|
US Biomax |
|
231 |
|
Publication |
| HN241 Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
HN241 |
Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| BC01014 Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 US Biomax 231 |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231 |
|
Publication |
| CR241 Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 cores US Biomax 88 |
CR241 |
Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC08015 Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728 US Biomax 160 |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160 |
|
Publication |
| CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores US Biomax 231 |
CR802 |
Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231 |
|
Publication |
| T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114 |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114 |
|
Publication |
| IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805 US Biomax 231 |
IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805
|
US Biomax |
|
231 |
|
Publication |
| SO481 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM information US Biomax 160 |
SO481 |
Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM information
|
US Biomax |
|
160 |
|
Publication |
| ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202 US Biomax 278 |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278 |
|
Publication |
| BC01011 Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 US Biomax 160 |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160 |
|
Publication |
| LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| T291 Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases 24 cores US Biomax 100 |
T291 |
Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases 24 cores
|
US Biomax |
|
100 |
|
Publication |
| CO242 Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores. US Biomax 88 |
CO242 |
Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.
|
US Biomax |
|
88 |
|
Publication |
| RE812 Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data US Biomax 231 |
RE812 |
Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data
|
US Biomax |
|
231 |
|
Publication |
| T433 Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T433 |
Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC12012 Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802 US Biomax 231 |
BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231 |
|
Publication |
| KD242 Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores US Biomax 88 |
KD242 |
Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| BC08013 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014 US Biomax 160 |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160 |
|
Publication |
| LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20810 |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV2089 |
Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| BC07013 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 US Biomax 160 |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160 |
|
Publication |
| CO802 Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801 US Biomax 189 |
CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189 |
|
Publication |
| BC19012 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 US Biomax 231 |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231 |
|
Publication |
| CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2087 |
Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores US Biomax 160 |
KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20810 |
Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| LV483 Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 cores US Biomax 160 |
LV483 |
Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| ST807 Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores US Biomax 231 |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| BC03013 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723 US Biomax 160 |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160 |
|
Publication |
| BC07012 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 US Biomax 160 |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160 |
|
Publication |
| CR483 Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data US Biomax 160 |
CR483 |
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data
|
US Biomax |
|
160 |
|
Publication |
| RE482 Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores US Biomax 160 |
RE482 |
Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| TP484 Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases 48 cores US Biomax 160 |
TP484 |
Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| LV242 Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
LV242 |
Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC11011 Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores US Biomax 160 |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160 |
|
Publication |
| BC08016 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803 US Biomax 160 |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160 |
|
Publication |
| BC03011 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010 US Biomax 160 |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160 |
|
Publication |
| LV802 Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801 US Biomax 189 |
LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189 |
|
Publication |
| BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231 |
|
Publication |
| SK484 Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores US Biomax 160 |
SK484 |
Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| PR242 Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
PR242 |
Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC07011 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 US Biomax 160 |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160 |
|
Publication |
| PA482 Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores, with TNM data US Biomax 160 |
PA482 |
Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores, with TNM data
|
US Biomax |
|
160 |
|
Publication |
| BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores
|
US Biomax |
|
278 |
|
Publication |
| BR803 Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 US Biomax 189 |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189 |
|
Publication |
| ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278 |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201
|
US Biomax |
|
278 |
|
Publication |
| BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20833 |
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 |
T262 |
Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T009 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T009 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| PR241 Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243 US Biomax 88 |
PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243
|
US Biomax |
|
88 |
|
Publication |
| BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide US Biomax 189 |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide
|
US Biomax |
|
189 |
|
Publication |
| LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231 |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
231 |
|
Publication |
| PA243 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
PA243 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
ES243 |
Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0012 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T383 Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T383 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| STC1021 Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores US Biomax 225 |
STC1021 |
Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores
|
US Biomax |
|
225 |
|
Publication |
| BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20832 |
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| OV208 Ovarian cancer and normal tissue high density (69 cases 208 cores) tissue microarray, with grade and stage data US Biomax 456 |
OV208 |
Ovarian cancer and normal tissue high density (69 cases 208 cores) tissue microarray, with grade and stage data
|
US Biomax |
|
456 |
|
Publication |
| LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T072 |
Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T213 Skin cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T213 |
Skin cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T008 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| ES242 Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases 24 cores US Biomax 88 |
ES242 |
Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228 |
|
Publication |
| T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0011 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| TH801 Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases 80 cores, no overlaps with TH802 US Biomax 231 |
TH801 |
Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases 80 cores, no overlaps with TH802
|
US Biomax |
|
231 |
|
Publication |
| BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| CO2083 High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| MC6162 High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores US Biomax 753 |
MC6162 |
High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores
|
US Biomax |
|
753 |
|
Publication |
| PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
PA1002 |
Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266 |
|
Publication |
| LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LC243 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T007 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
CO244 |
Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| T423 Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T423 |
Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0010 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| SK801 Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b US Biomax 278 |
SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278 |
|
Publication |
| T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T103 |
Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456 |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax |
|
456 |
|
Publication |
| HN242 Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
HN242 |
Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| T001 Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 |
T001 |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data US Biomax 456 |
BL208 |
Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data
|
US Biomax |
|
456 |
|
Publication |
| CO801 Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases 80 cores, no overlaps with CO802 US Biomax 231 |
CO801 |
Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases 80 cores, no overlaps with CO802
|
US Biomax |
|
231 |
|
Publication |
| BR2083 High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| T0014 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0014 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| OV8010 Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| PA241 Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b US Biomax 100 |
PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b
|
US Biomax |
|
100 |
|
Publication |
| OV243 Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
OV243 |
Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| PR482 Multiple prostate cancer tissue array with 4 normal tissue control from autopsy, with TNM and Gleason Scores, 24 cases 48 cores US Biomax 160 |
PR482 |
Multiple prostate cancer tissue array with 4 normal tissue control from autopsy, with TNM and Gleason Scores, 24 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| UT242 Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
UT242 |
Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax |
|
189 |
|
Publication |
| T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0013 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88 |
|
Publication |
| BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 US Biomax 266 |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266 |
|
Publication |
| BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 US Biomax 266 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266 |
|
Publication |
| SO208 Soft tissue sarcoma high density tissue array with normal controls, 69 cases 208 cores, with grade and stage data US Biomax 456 |
SO208 |
Soft tissue sarcoma high density tissue array with normal controls, 69 cases 208 cores, with grade and stage data
|
US Biomax |
|
456 |
|
Publication |
| BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278 |
|
Publication |
| T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 US Biomax 88 |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax |
|
88 |
|
Publication |
| BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax |
|
266 |
|
Publication |
| TH208 Thyroid cancer tissue microarray with normal tissue control, high density (60 cases 208 cores), with clinical stage data US Biomax 456 |
TH208 |
Thyroid cancer tissue microarray with normal tissue control, high density (60 cases 208 cores), with clinical stage data
|
US Biomax |
|
456 |
|
Publication |
| OV483 Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
OV483 |
Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info
|
US Biomax |
|
160 |
|
Publication |
| CR806 Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
CR806 |
Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| T382 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 |
T382 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 US Biomax 160 |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160 |
|
Publication |
| TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 US Biomax 88 |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241
|
US Biomax |
|
88 |
|
Publication |
| T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 |
T002 |
Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| KD483 Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade data US Biomax 160 |
KD483 |
Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade data
|
US Biomax |
|
160 |
|
Publication |
| T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| ST483 Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
ST483 |
Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info
|
US Biomax |
|
160 |
|
Publication |
| T303 Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T303 |
Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742 |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742 |
|
Publication |
| BR1004 Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010 US Biomax 314 |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314 |
|
Publication |
| LC242 Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88 |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171
|
US Biomax |
|
88 |
|
Publication |
| CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide US Biomax 160 |
CR243 |
Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide
|
US Biomax |
|
160 |
|
Publication |
| LC241 Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88 |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| PA483 Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with grade and stage data US Biomax 160 |
PA483 |
Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with grade and stage data
|
US Biomax |
|
160 |
|
Publication |
| T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax |
|
88 |
|
Publication |
| KD481 Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores US Biomax 160 |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160 |
|
Publication |
| ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031 US Biomax 231 |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231 |
|
Publication |
| FDA997 FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 US Biomax 314 |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314 |
|
Publication |
| T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T413 Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T413 |
Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases 208 cores, with grade and stage US Biomax 456 |
CR208 |
Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases 208 cores, with grade and stage
|
US Biomax |
|
456 |
|
Publication |
| BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases 45 cores, with ER, PR and P53 IHC results US Biomax 160 |
BR451 |
Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases 45 cores, with ER, PR and P53 IHC results
|
US Biomax |
|
160 |
|
Publication |
| CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information US Biomax 160 |
CO483 |
Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information
|
US Biomax |
|
160 |
|
Publication |
| T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T392 Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 US Biomax 88 |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax |
|
88 |
|
Publication |
| BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed US Biomax 185 |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185 |
|
Publication |
| T233 Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T233 |
Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T172 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88 |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052
|
US Biomax |
|
88 |
|
Publication |
| T391 Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392 US Biomax 88 |
T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392
|
US Biomax |
|
88 |
|
Publication |
| T194 Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88 |
|
Publication |
| LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320 |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax |
|
320 |
|
Publication |
| LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores US Biomax 456 |
LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
| CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189 |
|
Publication |
| T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 US Biomax 88 |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88 |
|
Publication |
| T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T052 |
Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88 |
T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385
|
US Biomax |
|
88 |
|
Publication |
| T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T212 |
Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores US Biomax 231 |
BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores
|
US Biomax |
|
231 |
|
Publication |
| LV208 Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info US Biomax 456 |
LV208 |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info
|
US Biomax |
|
456 |
|
Publication |
| LP208 High density larynx and pharynx cancer tissue array with normal tissue (69 cases 208 core) including stage and grade data US Biomax 456 |
LP208 |
High density larynx and pharynx cancer tissue array with normal tissue (69 cases 208 core) including stage and grade data
|
US Biomax |
|
456 |
|
Publication |
| MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231 |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax |
|
231 |
|
Publication |
| T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| T385 Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386 US Biomax 88 |
T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88 |
|
Publication |
| LC482 Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status US Biomax 160 |
LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160 |
|
Publication |
| HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483 US Biomax 160 |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160 |
|
Publication |
| OS208 High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases 208 cores US Biomax 456 |
OS208 |
High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
| PR952 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953 US Biomax 314 |
PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314 |
|
Publication |
| FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
| CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores US Biomax 456 |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
| FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380 |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
380 |
|
Publication |
| FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278 |
|
Publication |
| T381 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385 US Biomax 88 |
T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385
|
US Biomax |
|
88 |
|
Publication |
| T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| PR483 Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info US Biomax 160 |
PR483 |
Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info
|
US Biomax |
|
160 |
|
Publication |
| FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314 |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
314 |
|
Publication |
| OV951 Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores, US Biomax 456 |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456 |
|
Publication |
| RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 US Biomax 231 |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022
|
US Biomax |
|
231 |
|
Publication |
| PA801 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 US Biomax 231 |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231 |
|
Publication |
| LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185 |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185 |
|
Publication |
| FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278 |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278 |
|
Publication |
| IRPLG-10mg Rat Plasminogen 10mg Innovative Research INC 10mg 5673 |
IRPLG-10mg |
Rat Plasminogen 10mg
|
Innovative Research INC |
10mg |
5673 |
|
Publication |
| T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044
|
US Biomax |
|
88 |
|
Publication |
| T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199 |
FDA902 |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ
|
US Biomax |
|
199 |
|
Publication |
| T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| SM208 Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases 208 core, with stage and grade data US Biomax 456 |
SM208 |
Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases 208 core, with stage and grade data
|
US Biomax |
|
456 |
|
Publication |
| T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045
|
US Biomax |
|
99 |
|
Publication |
| MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
MGS801 |
Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266 |
|
Publication |
| MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634 |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001
|
US Biomax |
|
634 |
|
Publication |
| T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88 |
|
Publication |
| T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T223 |
Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
| LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267 |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax |
|
267 |
|
Publication |
| KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
| T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045
|
US Biomax |
|
88 |
|
Publication |
| T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88 |
|
Publication |
| KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456 |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores
|
US Biomax |
|
456 |
|
Publication |
| MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax |
|
382 |
|
Publication |
| FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626 |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
|
US Biomax |
|
626 |
|
Publication |
| MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
811 |
|
Publication |
| T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T093 |
Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax |
|
626 |
|
Publication |
| T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T273 |
Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320 |
|
Publication |
| ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626 |
|
Publication |
| T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T113 |
Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206 |
FDA902b |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing
|
US Biomax |
|
1206 |
|
Publication |
| T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
| PR953 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954 US Biomax 456 |
PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954
|
US Biomax |
|
456 |
|
Publication |
| FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax |
|
228 |
|
Publication |
| PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax |
|
105 |
|
Publication |
| BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429 |
|
Publication |
| PR951 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed US Biomax 487 |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487 |
|
Publication |
| FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456 |
|
Publication |
| T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T163 |
Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258 |
|
Publication |
| PR955 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954 US Biomax 558 |
PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954
|
US Biomax |
|
558 |
|
Publication |
| FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| LC1006 Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 US Biomax 231 |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231 |
|
Publication |
| PR954 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955 US Biomax 456 |
PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax |
|
456 |
|
Publication |
| BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456 |
|
Publication |
| FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626 |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax |
|
626 |
|
Publication |
| HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626 |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax |
|
626 |
|
Publication |
| T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90 |
|
Publication |
| PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296 |
|
Publication |
| BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804 US Biomax 231 |
BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231 |
|
Publication |
| BR6161 High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores US Biomax 753 |
BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores
|
US Biomax |
|
753 |
|
Publication |
| CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores US Biomax 266 |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266 |
|
Publication |
| BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores US Biomax 231 |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231 |
|
Publication |
| RE483 Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 188 |
RE483 |
Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
188 |
|
Publication |
| BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018 US Biomax 231 |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231 |
|
Publication |
| BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax |
|
336 |
|
Publication |
| PR631 Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores US Biomax 266 |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266 |
|
Publication |
| BCN962 Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases 96 cores US Biomax 231 |
BCN962 |
Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases 96 cores
|
US Biomax |
|
231 |
|
Publication |
| PR803 Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801 US Biomax 231 |
PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801
|
US Biomax |
|
231 |
|
Publication |
| KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases 24 cores US Biomax 88 |
KD241 |
Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| PR801 Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803 US Biomax 231 |
PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803
|
US Biomax |
|
231 |
|
Publication |
| CO809 Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases 80 cores US Biomax 263 |
CO809 |
Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases 80 cores
|
US Biomax |
|
263 |
|
Publication |
| CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456 |
|
Publication |
| BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores
|
US Biomax |
|
266 |
|
Publication |
| CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225 |
|
Publication |
| LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266 |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002
|
US Biomax |
|
266 |
|
Publication |
| GL208 Brain primary tumor high density (69 cases 208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue US Biomax 456 |
GL208 |
Brain primary tumor high density (69 cases 208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue
|
US Biomax |
|
456 |
|
Publication |
| T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T301 |
Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88 |
|
Publication |
| CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429 |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429 |
|
Publication |
| OR601 Oral squamous cancer tissue array with normal oral control tissue, 60 cases 60 cores US Biomax 231 |
OR601 |
Oral squamous cancer tissue array with normal oral control tissue, 60 cases 60 cores
|
US Biomax |
|
231 |
|
Publication |
| SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456 |
SO2083 |
Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456 |
|
